Treatment of breast cancer with danazol.
article
OA: closed
CC0
⤵ 3 in-corpus citations
Limited metadata. Only one source feed has indexed
this record so far — no abstract, full text, or open-access copy is
available through Endo Lab. The
publisher
is the canonical location for the actual content. If you have institutional
access, use "Find at my library".
AI-generated summary
This paper investigates the treatment of breast cancer with danazol, although no abstract is available to summarize specific findings or outcomes.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
My notes (saved in your browser only)
Citation neighborhood (sparse)
Too few in-corpus citations on either side for a chart; here are the lists.
Cited by (3)
- Inhibition of Adrenal Steroidogenesis by Danazol in Vivo 1980
- Short‐term effects of danazol and medroxyprogesterone acetate on cytosol and nuclear estrogen and progestin receptors, 17β‐hydroxysteroid dehydrogenase activity, histopathology, and ultrastructure of human endometrial adenocarcinoma 1985
- Progesterone receptor induction by danazol in cultured cancer cells and the rat uterus 1992
Cited by (3)
- Progesterone receptor induction by danazol in cultured cancer cells and the rat uterus 1992
- Short‐term effects of danazol and medroxyprogesterone acetate on cytosol and nuclear estrogen and progestin receptors, 17β‐hydroxysteroid dehydrogenase activity, histopathology, and ultrastructure of human endometrial adenocarcinoma 1985
- Inhibition of Adrenal Steroidogenesis by Danazol in Vivo 1980
Source provenance
- openalex
- last seen: 2026-05-10T10:43:42.427797+00:00
License: CC0
· commercial use OK